Journal: Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
Article Title: [Treatment and progression of acute communautary osteoarticular infections in healthy children: A retrospective monocentric study of 64Êpatients].
PMID/MRN: 27745829
Publication Date: 2016-Nov-30
Abstract:
The prognosis of osteoarticular infections has improved over the past 20Êyears but it still remains potentially severe. The treatment of these infections has been simplified and shortened. In 2008, the Pediatric Infectious Disease Group (GPIP) established new therapeutic guidelines in order to standardize treatment in France. The aim of this study is to analyze practices in a Parisian hospital and assess the efficacy of this treatment in short and medium terms.
This retrospective study focused on patients older than 3Êmonths, without comorbidities, who were hospitalized for an acute osteoarticular infection in 2012Êat Trousseau Hospital (Paris), with a follow-up of at least 4Êweeks. The patients were selected from the hospital register.
The study included 64Êpatients of 156, who were admitted for examination with a diagnosis of acute osteoarticular infection, bacteriologically confirmed (29/64) or presumed on the basis of bacteriological evidence (35/64). The median age of the patients was 22Êmonths. Of the patients, 78Ê% were febrile; 35Êpatients had arthritis (54.7Ê%), 21Êosteomyelitis (32.8Ê%), seven osteoarthritis (10.9Ê%), and one spondylitis. Preferential localizations were the knees and hips; 61Ê% of arthritis cases were diagnosed with ultrasound, 54Ê% of osteomyelitis cases with scintigraphy. The two main microorganisms found were Kingella kingae (62.1Ê%) and StaphylococcusÊaureus (24.1Ê%). In 98Ê% of cases, patients were treated by cefamandole, with or without gentamicine, for a median duration of 3Êdays (1-10) intravenously, with oral relay by amoxicillin-clavulanic acid, for a total duration of 6Êweeks, but in association with rifampicin in 40Ê% of cases without explanation. The median follow-up was 13Êweeks, with a treatment success rate of 86Ê%.
The study of local practices showed us that the GPIP guidelines are not followed, with the duration of oral treatment being too long. The trend in therapy is toward short treatments of 10-20Êdays, with a shorter intravenous phase.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.